BSE · DLCL
DR LALCHANDANI LABS LIMITED
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,802
of 5,088 stocks
▼ 1211W
Peak #4,681 · 21 Sep 2026
Operating in Healthcare, DR LALCHANDANI LABS LIMITED carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and is seeing revenue slip.
Market Cap
5.95 Cr
P/E Ratio
93.74
P/B Ratio
0.42
ROE
0.45%
ROCE
0.81%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
Quarterly financials for this stock haven't been ingested yet — check back soon.
Shareholding pattern
Promoter
32.90%
Public
67.10%
PUBLIC BREAKDOWN
Individuals
62.93%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 27 Jan 2026 | Other | Right Issue of Equity Shares |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.